BioLineRx Ltd - Company Profile
Powered by
All the data and insights you need on BioLineRx Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date BioLineRx Ltd Strategy Report
- Understand BioLineRx Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on BioLineRx Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
01 Apr 2024 | BioLineRx to Raise USD6 Million in Registered Direct Offering of American Depositary Shares | Equity Offering | - |
BioLineRx Ltd |
12 Oct 2023 | Guangzhou Gloria Biosciences Enters into Licensing Agreement with BioLineRx | Licensing Agreement |
Guangzhou Gloria Biosciences Co Ltd
|
BioLineRx Ltd |
12 Oct 2023 | Guangzhou Gloria Biosciences Invests USD14.6 Million in BioLineRx | Equity Offering |
Guangzhou Gloria Biosciences Co Ltd
|
BioLineRx Ltd |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer